Drafts are also provided to the Food and Drug Administration and Centers for Disease Control and Prevention and to all first authors of articles cited in the text. The evaluation of each drug includes a discussion of its efficacy, side effects, and a comparison with older, more established agents.
Drafts are also distributed to regulatory agencies such as the Food and Drug Administration and Centers for Disease Control and Prevention, as well as original authors of studies cited in the text. The assessment of each drug involves a consideration of its advantages and disadvantages, and a comparison with previous treatments.